{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T09:50:09Z","timestamp":1775901009655,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T00:00:00Z","timestamp":1708473600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"ISCIII","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018780","name":"Junta de Andaluc\u00eda Servicio Andaluz de Salud","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ijantimicag.2024.107116","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T11:04:25Z","timestamp":1708686265000},"page":"107116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Antiviral activity of immunosuppressors alone and in combination against human adenovirus and cytomegalovirus"],"prefix":"10.1016","volume":"63","author":[{"given":"Marta","family":"Carretero-Ledesma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela","family":"Aguilar-Guisado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Berastegui-Cabrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Balsera-Manzanero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8166-5308","authenticated-orcid":false,"given":"Jer\u00f3nimo","family":"Pach\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7766-7266","authenticated-orcid":false,"given":"Elisa","family":"Cordero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2707-1979","authenticated-orcid":false,"given":"Javier","family":"S\u00e1nchez-C\u00e9spedes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2024.107116_bib0001","doi-asserted-by":"crossref","first-page":"e12961","DOI":"10.1111\/tid.12961","article-title":"The clinical and economic impact of cytomegalovirus infection in recipients of hematopoietic stem cell transplantation","volume":"20","author":"Webb","year":"2018","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.ijantimicag.2024.107116_bib0002","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1128\/CMR.00116-13","article-title":"Adenovirus infections in immunocompetent and immunocompromised patients","volume":"27","author":"Lion","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2024.107116_bib0003","article-title":"Case Report: Management of a multidrug-resistant CMV-strain in a renal transplant recipient by high-dose CMV-specific immunoglobulins, modulation in immunosuppression, and induction of CMV-specific cellular immunity","volume":"11","author":"Wiening","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijantimicag.2024.107116_bib0004","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.antiviral.2016.07.017","article-title":"Mycophenolic acid potently inhibits rotavirus infection with a high barrier to resistance development","volume":"133","author":"Yin","year":"2016","journal-title":"Antiviral Res"},{"key":"10.1016\/j.ijantimicag.2024.107116_bib0005","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/ctr.12552","article-title":"The effect of sirolimus-based immunosuppression vs. conventional prophylaxis therapy on cytomegalovirus infection after liver transplantation","volume":"29","author":"Sheng","year":"2015","journal-title":"Clin Transplant"},{"key":"10.1016\/j.ijantimicag.2024.107116_bib0006","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s12185-022-03428-3","article-title":"Systematic overview of HLA-matched allogeneic hematopoietic cell transplantation with post-transplantation cyclophosphamide","volume":"116","author":"Nakamae","year":"2022","journal-title":"Int J Hematol"},{"key":"10.1016\/j.ijantimicag.2024.107116_bib0007","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF02678145","article-title":"Bone mass and mineral metabolism in liver transplant patients treated with FK506 or cyclosporine A","volume":"68","author":"Monegal","year":"2001","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.ijantimicag.2024.107116_bib0008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173303","article-title":"Investigating antimalarial drug interactions of emetine dihydrochloride hydrate using CalcuSyn-based interactivity calculations","volume":"12","author":"Matthews","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2024.107116_bib0009","first-page":"61","article-title":"Inhibition of calcineurin or IMP dehydrogenase exerts moderate to potent antiviral activity against norovirus replication","author":"Dang","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2024.107116_bib0010","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1002\/hep.25562","article-title":"Mycophenolic acid augments interferon-stimulated gene expression and inhibits hepatitis C virus infection in vitro and in vivo","volume":"55","author":"Pan","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.ijantimicag.2024.107116_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2019.103762","article-title":"Mycophenolic acid (MPA) modulates host cellular autophagy progression in sub genomic dengue virus-2 replicon cells","volume":"137","author":"Manchala","year":"2019","journal-title":"Microb Pathog"},{"key":"10.1016\/j.ijantimicag.2024.107116_bib0012","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nrgastro.2012.67","article-title":"Virus\u2013drug interactions \u2013 molecular insight into immunosuppression and HCV","volume":"9","author":"Pan","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ijantimicag.2024.107116_bib0013","doi-asserted-by":"crossref","first-page":"594","DOI":"10.4103\/ijo.IJO_1352_18","article-title":"Comparison of the safety and efficacy of topical tacrolimus (0.03%) versus dexamethasone (0.05%) for subepithelial infiltrates after adenoviral conjunctivitis","volume":"67","author":"Bhargava","year":"2019","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.ijantimicag.2024.107116_bib0014","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1002\/jmv.26512","article-title":"Methotrexate inhibits SARS-CoV-2 virus replication \"in vitro\"","volume":"93","author":"Caruso","year":"2021","journal-title":"J Med Virol"},{"key":"10.1016\/j.ijantimicag.2024.107116_bib0015","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41409-020-01044-5","article-title":"Carfilzomib combined with cyclosporine and methotrexate for the prevention of graft-versus-host disease after allogeneic stem-cell transplantation from unrelated donors","volume":"56","author":"Shimoni","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.ijantimicag.2024.107116_bib0016","first-page":"645","article-title":"Bioavailability of higher dose methotrexate comparing oral and subcutaneous administration in patients with rheumatoid arthritis","volume":"31","author":"Hoekstra","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ijantimicag.2024.107116_bib0017","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2125.1979.tb01004.x","article-title":"Pharmacokinetics of cyclophosphamide and alkylating activity in man after intravenous and oral administration","volume":"8","author":"Juma","year":"1979","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2024.107116_bib0018","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2165\/00003088-200443020-00002","article-title":"Clinical pharmacokinetics of everolimus","volume":"43","author":"Kirchner","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ijantimicag.2024.107116_bib0019","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00003088-200746010-00002","article-title":"Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients","volume":"46","author":"Staatz","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ijantimicag.2024.107116_bib0020","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1007\/s00228-012-1275-9","article-title":"Population pharmacokinetics and Bayesian estimation of cyclosporine in a Tunisian population of hematopoietic stem cell transplant recipient","volume":"68","author":"Eljebari","year":"2012","journal-title":"Eur J Clin Pharmacol"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857924000347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857924000347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T06:27:34Z","timestamp":1714285654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857924000347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0924857924000347"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2024.107116","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiviral activity of immunosuppressors alone and in combination against human adenovirus and cytomegalovirus","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2024.107116","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107116"}}